Olaparib monotherapy for BRIP1-mutated high-grade serous endometrial cancer

Kohei Nakamura; Eriko Aimono; Shigeki Tanishima; Mitsuho Imai; Akiko Kawano Nagatsuma; Hideyuki Hayashi; Yuki Yoshimura; Kentaro Nakayama; Satoru Kyo; Hiroshi Nishihara

doi:10.1200/PO.19.00368

Olaparib monotherapy for BRIP1-mutated high-grade serous endometrial cancer

Kohei Nakamura, Eriko Aimono, Shigeki Tanishima, Mitsuho Imai, Akiko Kawano Nagatsuma, Hideyuki Hayashi, Yuki Yoshimura, Kentaro Nakayama, Satoru Kyo, Hiroshi Nishihara

Research output: Contribution to journal › Article › peer-review

10 Citations (Scopus)

Original language	English
Pages (from-to)	283-290
Number of pages	8
Journal	JCO Precision Oncology
Volume	3
DOIs	https://doi.org/10.1200/PO.19.00368
Publication status	Published - 2019

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/PO.19.00368

Cite this

@article{93f91893771a4159baca4664df45c9ec,

title = "Olaparib monotherapy for BRIP1-mutated high-grade serous endometrial cancer",

author = "Kohei Nakamura and Eriko Aimono and Shigeki Tanishima and Mitsuho Imai and Nagatsuma, {Akiko Kawano} and Hideyuki Hayashi and Yuki Yoshimura and Kentaro Nakayama and Satoru Kyo and Hiroshi Nishihara",

note = "Funding Information: Supported by the Japan Agency for Medical Research and Development under Grant No. JP 16kk0205006.",

year = "2019",

doi = "10.1200/PO.19.00368",

language = "English",

volume = "3",

pages = "283--290",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Olaparib monotherapy for BRIP1-mutated high-grade serous endometrial cancer

AU - Nakamura, Kohei

AU - Aimono, Eriko

AU - Tanishima, Shigeki

AU - Imai, Mitsuho

AU - Nagatsuma, Akiko Kawano

AU - Hayashi, Hideyuki

AU - Yoshimura, Yuki

AU - Nakayama, Kentaro

AU - Kyo, Satoru

AU - Nishihara, Hiroshi

N1 - Funding Information: Supported by the Japan Agency for Medical Research and Development under Grant No. JP 16kk0205006.

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85086461546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086461546&partnerID=8YFLogxK

U2 - 10.1200/PO.19.00368

DO - 10.1200/PO.19.00368

M3 - Article

AN - SCOPUS:85086461546

SN - 2473-4284

VL - 3

SP - 283

EP - 290

JO - JCO Precision Oncology

JF - JCO Precision Oncology

ER -

Olaparib monotherapy for BRIP1-mutated high-grade serous endometrial cancer

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this